Free Trial

Health In Tech (NASDAQ:HIT) Lowered to "Buy" Rating by Wall Street Zen

Health In Tech logo with Finance background

Key Points

  • Health In Tech (NASDAQ:HIT) was downgraded from a "strong-buy" to a "buy" rating by analysts at Wall Street Zen.
  • Maxim Group upgraded Health In Tech to a "strong-buy" rating with a target price of $2.50 per share.
  • The company's recent quarterly earnings met expectations with reported earnings per share (EPS) of $0.01 and revenue of $9.31 million, exceeding forecasts.
  • Five stocks to consider instead of Health In Tech.

Health In Tech (NASDAQ:HIT - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a report released on Saturday.

Separately, Maxim Group raised shares of Health In Tech to a "strong-buy" rating and set a $2.50 price target on the stock in a research note on Thursday, June 26th.

Check Out Our Latest Stock Analysis on HIT

Health In Tech Price Performance

NASDAQ:HIT traded down $0.40 during trading hours on Friday, hitting $2.88. 727,805 shares of the stock traded hands, compared to its average volume of 1,315,582. The firm has a 50 day moving average price of $1.24 and a 200 day moving average price of $2.13. Health In Tech has a fifty-two week low of $0.51 and a fifty-two week high of $7.59.

Health In Tech (NASDAQ:HIT - Get Free Report) last announced its earnings results on Monday, July 21st. The company reported $0.01 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.01. The firm had revenue of $9.31 million for the quarter, compared to analyst estimates of $7.96 million.

Hedge Funds Weigh In On Health In Tech

A number of hedge funds have recently modified their holdings of the stock. XTX Topco Ltd bought a new stake in Health In Tech during the first quarter valued at about $59,000. Jane Street Group LLC acquired a new position in Health In Tech in the first quarter worth about $48,000. Arete Wealth Advisors LLC acquired a new stake in shares of Health In Tech during the first quarter worth approximately $47,000. Finally, Cubist Systematic Strategies LLC acquired a new stake in shares of Health In Tech during the first quarter worth approximately $41,000.

About Health In Tech

(Get Free Report)

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

Read More

Should You Invest $1,000 in Health In Tech Right Now?

Before you consider Health In Tech, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Health In Tech wasn't on the list.

While Health In Tech currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines